Reversible Cerebral Vasoconstriction Syndrome Presenting with Bilateral Occipital Hemorrhage after the Subcutaneous Injection of Synthetic Gonadotropin Releasing Hormone.
10.17340/jkna.2017.35.3.7
- Author:
Inyoung CHUNG
1
;
Dallah YOO
;
Cheolkyu JUNG
;
Moon Ku HAN
Author Information
1. Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. mkhan@snu.ac.kr
- Publication Type:Case Report
- Keywords:
Reversible cerebral vasoconstriction syndrome;
Intracerebral hemorrhage;
Synthetic analogue of gonadotropin releasing hormone
- MeSH:
Cerebral Hemorrhage;
Cerebrovascular Disorders;
Estrogens;
Gonadotropin-Releasing Hormone*;
Gonadotropins*;
Hemorrhage*;
Injections, Subcutaneous*;
Relaxation;
Vasoconstriction*
- From:Journal of the Korean Neurological Association
2017;35(3):151-154
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Reversible cerebral vasoconstriction syndrome (RCVS) is a heterogeneous group of cerebrovascular disease. The pathophysiology of RCVS is unknown, but a disturbance in cerebral vascular tone is one of hypothesis. Long-term use of Gonadotropin-releasing hormone (GnRH) agonists can induce a pseudomenopausal state in which estrogen production are suppressed. It might lead to reduced arterial relaxation by estrogen withdrawal. We report a case of RCVS after the injection of synthetic analogue of GnRH.
